兴齐眼药
(300573)
| 流通市值：250.37亿 | | | 总市值：325.93亿 |
| 流通股本：9570.65万 | | | 总股本：1.25亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 349,876,258.51 | 1,467,569,910.64 | 1,104,863,512.43 | 685,470,748.67 |
| 营业收入 | 349,876,258.51 | 1,467,569,910.64 | 1,104,863,512.43 | 685,470,748.67 |
| 二、营业总成本 | 313,254,777.41 | 1,199,346,664.84 | 899,950,615.19 | 587,085,529.98 |
| 营业成本 | 83,613,127.86 | 332,060,686.39 | 247,699,228.92 | 162,070,007.66 |
| 税金及附加 | 4,056,673.99 | 16,412,745.22 | 12,560,548.63 | 7,896,895.01 |
| 销售费用 | 150,010,641.54 | 535,307,555.99 | 410,557,690.1 | 271,778,337.01 |
| 管理费用 | 38,700,347.91 | 154,493,782.18 | 112,529,652.84 | 71,137,985.92 |
| 研发费用 | 38,068,318.45 | 167,297,173.93 | 121,550,678.54 | 77,709,577.37 |
| 财务费用 | -1,194,332.34 | -6,225,278.87 | -4,947,183.84 | -3,507,272.99 |
| 其中:利息费用 | 605,373.54 | 1,437,894.5 | 815,911.99 | 342,696.21 |
| 其中:利息收入 | 1,848,265.32 | 7,913,567.96 | 5,923,279.06 | 3,948,178.52 |
| 资产处置收益 | - | -37,533.51 | -31,590.78 | -31,590.78 |
| 资产减值损失(新) | 1,760,657.01 | -8,294,372.76 | -2,752,899.4 | -2,582,397.13 |
| 信用减值损失(新) | 1,189,127.76 | -3,732,339.6 | -4,359,935.51 | -4,471,901.02 |
| 其他收益 | 7,679,862.12 | 20,360,807.74 | 14,048,774.83 | 9,984,954.99 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 47,251,127.99 | 276,519,807.67 | 211,817,246.38 | 101,284,284.75 |
| 加:营业外收入 | - | 95,561.9 | 85,561.9 | 77,561.9 |
| 减:营业外支出 | 5,595,172 | 11,622,101.2 | 9,211,383.2 | 8,300,000 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 41,655,955.99 | 264,993,268.37 | 202,691,425.08 | 93,061,846.65 |
| 减:所得税费用 | 6,906,991.12 | 24,957,221.25 | 20,359,913.44 | 5,307,205.39 |
| 六、净利润 | 34,748,964.87 | 240,036,047.12 | 182,331,511.64 | 87,754,641.26 |
| 持续经营净利润 | 34,748,964.87 | 240,036,047.12 | 182,331,511.64 | 87,754,641.26 |
| 归属于母公司股东的净利润 | 34,748,964.87 | 240,036,047.12 | 182,331,511.64 | 87,754,641.26 |
| (一)基本每股收益 | 0.28 | 1.93 | 1.47 | 0.99 |
| (二)稀释每股收益 | 0.28 | 1.93 | 1.47 | 0.99 |
| 九、综合收益总额 | 34,748,964.87 | 240,036,047.12 | 182,331,511.64 | 87,754,641.26 |
| 归属于母公司股东的综合收益总额 | 34,748,964.87 | 240,036,047.12 | 182,331,511.64 | 87,754,641.26 |
| 公告日期 | 2024-04-26 | 2024-04-19 | 2023-10-24 | 2023-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | 标准无保留意见 |